Patients with high baseline gut richness and diversity have significantly greater decreases in diversity over time. by Molly B. El Alam (10231830)

Table_1_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…<p>In a previous study, we showed that viniferin decreased amyloid deposits and reduced neuroinflammation in APPswePS1dE9 transgenic mice between 3 and 6 months of age. …”

Image_1_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…<p>In a previous study, we showed that viniferin decreased amyloid deposits and reduced neuroinflammation in APPswePS1dE9 transgenic mice between 3 and 6 months of age. …”

Image_3_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…<p>In a previous study, we showed that viniferin decreased amyloid deposits and reduced neuroinflammation in APPswePS1dE9 transgenic mice between 3 and 6 months of age. …”

Image_2_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…<p>In a previous study, we showed that viniferin decreased amyloid deposits and reduced neuroinflammation in APPswePS1dE9 transgenic mice between 3 and 6 months of age. …”

Table_2_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…<p>In a previous study, we showed that viniferin decreased amyloid deposits and reduced neuroinflammation in APPswePS1dE9 transgenic mice between 3 and 6 months of age. …”

Image_4_Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model.pdf by Aline Freyssin (11912204)

“…<p>In a previous study, we showed that viniferin decreased amyloid deposits and reduced neuroinflammation in APPswePS1dE9 transgenic mice between 3 and 6 months of age. …”

IRI group exhibited a significantly greater decrease in proportion of gambles accepted compared to the IRI group in the second block. by Yasuhiro Mochizuki (3308349)

Chronic, but not acute, CCI mice have increased susceptibility to 30mg/kg PTZ. by Simone A. A. Romariz (16541996)

Subjects:

CCI - Chlorophyll Content Index. by Dominika Radzikowska-Kujawska (14439076)

Decrease of soil acidity has greater effects than increase of aboveground carbon inputs on soil organic carbon in terrestrial ecosystems of China under nitrogen enrichment by xiaofei Lu (11679673)

“…<a>Although the meta-analysis revealed that N addition significantly enhanced plant biomass and SOC concentration across the selected studies, we found that SOC concentration was independent of, or even decreased with, the enhanced plant biomass due to increased soil C loss as increasing organic C inputs. …”

NgR1 mutant mice exhibit increased susceptibility to PTZ-induced seizures after CCI. by Jinwei Zhang (462455)

“…<p>Seizure severity was assessed by determining the maximum clinical epileptic score (a) and the number of NgR1 KO and WT mice with myoclonic jerks (stage 3) or above seizures (b) within 60 min following PTZ administration. (a) In CCI model mice received PTZ to induced seizure, the clinical seizure score of NgR1 KO mice was significantly increased compared with WT group, and the difference was significant (WT mice, n = 17; NgR1 KO mice, n = 15. …”

S1 Data - by Simone A. A. Romariz (16541996)

Subjects:

Time-dependent effects of CCI on glutamate transporter mRNA. by Simone A. A. Romariz (16541996)

Subjects:

Delayed treatment with ceftriaxone reduced seizure susceptibility in CCI mice. by Simone A. A. Romariz (16541996)

Subjects:

Delayed treatment with ceftriaxone increases glutamate transporter mRNA in cortex and hippocampus. by Simone A. A. Romariz (16541996)

Subjects:

CCI score and blood culture dataset. by Patricia M. Tauran (13123978)

“…There was no association between increasing CCI score and positive BC (OR 1.01, 95%CI: 0.96-1.06, p = 0.69) after adjustment for age, sex and other potential confounders. …”

Significant interactions and main effects of day. by Grace Hecker (18813445)

Subjects:

As compared to HD, RRMS and T1D patients show significantly greater preponderance of rs2281808 CT/TT carriers. by Sushmita Sinha (348580)

Correlation coefficient between CCI and HCI categorized by sex and age. by Shimpei Goto (14856845)